SEC Filing Summary: Reviv3 Procare Company (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Reviv3 Procare Company on January 4, 2024. The report serves to announce the Company's consolidated financial results for the three-month period ended November 30, 2023. The filing incorporates by reference a press release (Exhibit 99.1) containing the detailed results.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1), which is furnished but not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Material Changes
The document does not disclose specific material changes versus prior periods. It solely references the issuance of the press release regarding the three months ended November 30, 2023.
Guidance, Outlook, and Risks
No specific guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed within the body of this 8-K filing. The registrant notes that the information in the attached press release is not subject to liability under Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Press Release) for actual revenue, net income, and cash flow figures for the quarter ended November 30, 2023.
- Verify the Company's current stock trading status, as the filing indicates "None" for securities registered under Section 12(b).
- Confirm the Company's address and contact information: 901 Fremont Avenue, Unit 158, Alhambra, CA 91803.
- Check for any subsequent filings that may provide updated financial data or clarify the status of the referenced press release.